Trevena Inc (TRVN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Trevena Inc Borsa (TRVN) Ultime notizie

Trevena Inc (TRVN)

Trevena Inc Borsa (TRVN) Ultime notizie

Trevena Announces Board and Executive ChangesOn January 31, 2025, Trevena, Inc. (NASDAQ:TRVN) filed a Form 8-K with the Securities and Exchange Commission, detailing significant departures and appointments within the company.In line with ongoin - Defense World

Trevena Implements Cost-Cutting Measures Amid Leadership Changes - TipRanks

Trevena (NASDAQ:TRVN) Shares Cross Below 200 Day Moving Average – Time to Sell? - Defense World

StockNews.com Begins Coverage on Trevena (NASDAQ:TRVN) - Defense World

StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN) - Defense World

Trevena discontinues OLINVYK injection sales By Investing.com - Investing.com Canada

Trevena discontinues OLINVYK injection sales - Investing.com

Trevena (NASDAQ:TRVN) Stock Price Crosses Above Fifty Day Moving Average – What’s Next? - Defense World

Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com - Defense World

Trevena Announces FDA Acceptance For Review Of New Drug Application For OLINVO(Oliceridine) Injection - Reuters.com

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com - Defense World

Trevena Announces Reverse Stock Split to Regain Nasdaq Compliance - MSN

With a 1.8% CAGR, the Opioid Market is Expected to Reach USD 28.45 billion by 2034 | PMR - GlobeNewswire

Trevena's SWOT analysis: CNS drug developer's stock faces pivotal moment - Investing.com

Trevena's SWOT analysis: stock outlook amid pipeline focus and financial moves - Investing.com Canada

Trevena's SWOT analysis: stock outlook amid pipeline focus and financial moves By Investing.com - Investing.com South Africa

Trevena (TRVN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Compass Therapeutics Appoints Barry Shin as Chief Financial Officer - citybiz

Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer - The Manila Times

Compass Therapeutics Taps Industry Veteran Barry Shin as CFO Ahead of Pivotal Clinical Data - StockTitan

Compass Therapeutics Names Barry Shin Chief Financial Officer - MarketWatch

Trevena appoints new financial chief - Investing.com

Trevena appoints new financial chief By Investing.com - Investing.com Nigeria

Trevena Appoints Katrine Sutton as New CFO - TipRanks

Trevena, Inc. Appoints Katrine Sutton as Principal Financial Officer and Principal Accounting Officer - Marketscreener.com

Trevena, Inc. Navigates Financial Challenges and Strategic Changes - MSN

Post-operative Pain Therapeutics Market Future Prospects, - openPR

ARMISTICE CAPITAL, LLC Acquires New Stake in Trevena Inc - GuruFocus.com

Trevena downgraded to Neutral from Buy at H.C. Wainwright - TipRanks

Trevena Inc. Reports Q3 2024 Financial Results - TipRanks

What to look for when Lowe’s (LOW) reports Q3 2024 earnings results - AlphaStreet

Ultragenyx Q3 Loss Narrower Than Expected, Revenues Beat Estimates - MSN

Postoperative Pain Therapeutics Market Trends, Business Overview, Industry Growth and Forecast to 2031 - openPR

Trevena Inc. (TRVN) Quarterly 10-Q Report - Quartz

Chester County biopharm firm's latest layoffs impact its C-suite - The Business Journals

Trevena: Q3 Earnings Snapshot - San Francisco Chronicle

Trevena Faces Leadership Changes Amidst Financial Challenges - TipRanks

Trevena, Inc. Announces Board Changes - Marketscreener.com

Trevena Reports Third Quarter 2024 Results and Provides Business Update - StockTitan

CVS Health books $1.2 bn in restructuring charges with new CEO comments in focus - MSN

Why Viking Therapeutics Stock Plummeted After Soaring Today - MSN

23andMe appoints new board members as it works to stem the company's slide - MSN

Sequoia buys South Carolina RIA Family Asset Management - MSN

Opioids Market Size to be worth $15.03 Billion By 2031: The Insight Partners - finanznachrichten.de

23andMe appoints three new board members following abrupt resignations - MSN

Post Operative Pain Therapeutics Market to Witness Huge Growth - openPR

Simile a TRVN